Impact of the motor complications of Parkinson's disease on the quality of life

Movement Disorders : Official Journal of the Movement Disorder Society
Stéphane ChapuisFranck Durif

Abstract

The impact of motor complications of Parkinson's disease (PD), especially levodopa-induced dyskinesias, on quality of life (QL) was studied in 143 patients with PD. All were evaluated on the Hoehn and Yahr (H&Y) scale, and the Motor part of the Unified Parkinson's Disease Rating Scale (UPDRS). Motor complications were analyzed using the UPDRS Parts IV(A) and IV(B) and the Abnormal Involuntary Movement Scale. A specific Parkinson's disease quality of life questionnaire (39-item version, PDQ-39) was used. Motor complications significantly worsened the PDQ-39 Summary Index (PDQ-SI) of patients with PD. The dimensions of Mobility, Activities of Daily Living, Stigma, and Communication were the most strongly affected. "Peak dose" dyskinesia decreased Mobility, Emotional Well-Being, and Cognition, whereas biphasic dyskinesia affected Mobility, Stigma, Communication, and Activities of Daily Living. Morning akinesia, end-of-dose fluctuations, and "unpredictable offs" decreased QL on the dimensions of Mobility, Activities of Daily Living, Stigma, and Communication. Nocturnal akinesia led to a deterioration of all dimensions of the PDQ-39. Thus, motor complications and especially nocturnal akinesia and biphasic dyskinesias worsened the QL...Continue Reading

References

Feb 1, 1976·Acta Neurologica Scandinavica·R J Marttila, U K Rinne
Jul 11, 1992·Journal of Geriatric Psychiatry and Neurology·W T LongstrethD Muñoz
Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Feb 22, 1986·British Medical Journal·W J MutchS K Roy
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·V PetoR Greenhall
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·R MarconiY Agid
Aug 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·M J BardsleyP D Home
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergJ A Aarli
Jul 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·A G de BoerJ C de Haes
Jun 6, 1996·Health Policy·R Brooks
Apr 14, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·K H KarlsenJ G Maeland
Apr 28, 1999·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·P A KoplasM Schenkman
Jun 11, 1999·Neurología : publicación oficial de la Sociedad Española de Neurología·P Martínez-Martín
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Sep 2, 2000·Current Opinion in Neurology·C M Tanner, D A Aston
Sep 12, 2000·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A M DamianoE D Means
Oct 26, 2000·Brain : a Journal of Neurology·A Schrag, N Quinn
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·A SchragN Quinn
Feb 13, 2002·Neurology·R Figueiras-MéndezC M Magariños-Ascone

❮ Previous
Next ❯

Citations

Apr 28, 2010·Der Nervenarzt·J Herzog, G Deuschl
Nov 19, 2008·Journal of Neurology·Francesca Del Sorbo, Alberto Albanese
Nov 26, 2010·Journal of Neurology·Angelo AntoniniMauro Plebani
Nov 26, 2010·Journal of Neurology·E HametnerW Poewe
Oct 20, 2010·Journal of Neurology·Juan Carlos Gómez-EstebanJuan J Zarranz
Apr 10, 2007·Journal of Neural Transmission·T MüllerD A Haeger
Mar 23, 2012·Journal of Neural Transmission·Alexander KhlebtovskyRuth Djaldetti
Dec 12, 2012·Journal of Neural Transmission·Manuela PilleriAngelo Antonini
Mar 5, 2013·Journal of Neural Transmission·K Ray ChaudhuriKapil D Sethi
May 31, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Pablo Martinez-MartinMaria Soledad Serrano
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yi WangWei-dong Le
Nov 6, 2009·Aging & Mental Health·Tatiana DubayovaJohan W Groothoff
May 3, 2007·Journal of Palliative Medicine·Lauren B ElmanLeo McCluskey
Oct 23, 2009·Brain : a Journal of Neurology·Elena MoroAndres M Lozano
Jul 5, 2008·The Nurse Practitioner·Mickie Welsh
Apr 3, 2008·Clinical Neuropharmacology·Mark Stacy, Andrew Galbreath
Jan 26, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N KlepacT Babić
Mar 8, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E HavlikovaJ W Groothoff
Jan 17, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C VossiusJ P Larsen
Jun 8, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A E EliaA Albanese
Sep 8, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F Stocchi, J M Rabey
Jan 10, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O Gershanik, P Jenner
Apr 13, 2012·Parkinson's Disease·John C P Piedad, Andrea E Cavanna
Jan 11, 2007·European Neurology·J C Gómez-EstebanI Garamendi
Nov 29, 2007·Neuroepidemiology·Dirk WoitallaDoris-Anita Haeger
Oct 27, 2012·BMC Palliative Care·Johan Lokk, Ahmad Delbari
Jan 11, 2011·PloS One·Hideyuki SawadaUNKNOWN Amantadine Study Group
Dec 1, 2007·Clinical Interventions in Aging·Fabrizio Stocchi, Maria Francesca De Pandis
Sep 16, 2010·CNS Drugs·Angelo AntoniniGiovanni Abbruzzese
Jul 1, 2010·Annals of African Medicine·F SalawuA Danburam
Dec 11, 2013·CNS Drugs·Marina Senek, Dag Nyholm
Apr 23, 2013·Journal of the Neurological Sciences·Xiaoyan GuoHui-Fang Shang
Jul 19, 2014·Brain : a Journal of Neurology·Roberto CiliaGianni Pezzoli
Sep 30, 2008·Journal of Neurology·M VisserJ J van Hilten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Parkinsonism & Related Disorders
M BehariR M Pandey
Movement Disorders : Official Journal of the Movement Disorder Society
Anette SchragN Quinn
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Y J ZhaoN Luo
Movement Disorders : Official Journal of the Movement Disorder Society
Shibley RahmanMarjan Jahanshahi
Journal of Neurology, Neurosurgery, and Psychiatry
Anette SchragN Quinn
© 2021 Meta ULC. All rights reserved